Vesper Bio ApS ("Vesper" or "the Company"), a clinical stage biotech developing novel oral therapies for neurodegenerative and neuropsychiatric diseases, today announces positive topline results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback